Gastric ulcers are sores on the stomach lining that form when the stomach’s protective defenses weaken against acid and pepsin. They belong to peptic ulcer disease and range from mild to severe, sometimes leading to bleeding or perforation. Modern treatments have improved healing outcomes. In this content, learn about gastric ulcer symptoms and treatments. Further learn more from

Causes of Gastric Ulcers
Gastric ulcers form when harmful factors overcome the stomach’s defenses—most commonly infection and medication exposure.
Helicobacter pylori Infection
A gram-negative bacterium, H. pylori, infects the stomach lining, produces urease to survive acid, and causes chronic inflammation that disrupts the mucosal barrier. See
.
NSAID Use
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostaglandin synthesis, reducing protective mucus and bicarbonate and directly irritating gastric mucosa—raising ulcer risk. Other contributors include severe physiological stress/critical illness (ischemia), smoking, alcohol, and rare hypersecretory states (e.g., Zollinger–Ellison). Corticosteroids alone are uncommon primary causes but may add risk with NSAIDs.
Epidemiology and Risk Factors
Peptic ulcer disease affects a notable proportion of the population (often cited single-digit to low double-digit lifetime prevalence), with H. pylori prevalence varying widely by region and socioeconomic status. Risk increases with age and with use of medications that impair mucosal defenses.
Key risk factors: chronic NSAID use, H. pylori infection, older age; plus smoking, heavy alcohol intake, prior ulcer history, and combined medications (e.g., NSAIDs with steroids or SSRIs).
How Gastric Ulcers Develop
Normally, mucus and bicarbonate form a protective barrier at the mucosal surface. When defenses are diminished and aggressive factors (acid, pepsin) dominate—exacerbated by H. pylori–driven inflammation or prostaglandin inhibition from NSAIDs—erosions can deepen into ulcers. Persistent injurious factors hinder healing and raise complication risks.
Gastric Ulcer Symptoms and Treatments
Common symptoms include epigastric burning/gnawing pain (often worse with eating for gastric ulcers), nausea, bloating, and early satiety. Occult or overt bleeding may present as melena or hematemesis. Some ulcers are asymptomatic and discovered on endoscopy. Red-flag symptoms (e.g., weight loss, persistent vomiting, anemia, bleeding) merit urgent evaluation.
Diagnosis and Staging
How is H. pylori ulcer diagnosed? Upper endoscopy (EGD) is the most reliable method to visualize ulcers, assess size/location, and obtain biopsies to exclude malignancy and detect H. pylori. See
. Nonendoscopic tests include urea breath test and stool antigen testing for H. pylori, plus labs (CBC for anemia, iron studies for chronic blood loss). During bleeding, the Forrest classification helps stratify endoscopic stigmata of recent hemorrhage and guide management.
Treatment Approaches
Management aims to heal the ulcer and prevent recurrence. Acid suppression with proton pump inhibitors (PPIs) is standard; H2 receptor blockers can be alternatives if PPIs are not tolerated. Antacids provide short-term symptom relief.
H. pylori Eradication
In confirmed infection, eradication therapy (typically PPI + two or more antibiotics per local resistance patterns) is essential, with test-of-cure weeks after completion. See
. If possible, discontinue or reduce NSAIDs; when needed, use the lowest effective dose and consider co-therapy with a PPI. In active bleeding, endoscopic hemostasis (injection, thermal coagulation, clips) is indicated. Surgery is reserved for complications (uncontrolled bleeding, perforation, or suspected malignancy). Supportive measures (smoking cessation, moderating alcohol, stress management, and nutrition) aid recovery.
Future Trends and Prevention Strategies
Prevention pairs lifestyle measures (avoid tobacco, limit alcohol, balanced diet, adequate hydration) with medication review (NSAID minimization, gastroprotection for high-risk users) and H. pylori test-and-treat strategies in appropriate populations.
Personalized Medicine
Ongoing work includes biomarker-guided risk stratification and individualized dosing choices (e.g., PPIs/NSAIDs), aligning therapy with patient-specific risks and responses.
Advanced Endoscopic Techniques
Improved imaging (e.g., narrow-band imaging) and AI-assisted detection may enhance early recognition and targeted therapy, potentially shortening time to treatment.
Public-health initiatives—safe NSAID education and expanded H. pylori screening where appropriate—can reduce population burden.
Frequently Asked Questions (FAQs)
1) What are the main causes of gastric ulcers?
Most commonly H. pylori infection and long-term NSAID use; other contributors include smoking, alcohol, severe illness, and rare hypersecretory states.
2) How is H. pylori diagnosed?
Via endoscopic biopsy-based tests or noninvasive urea breath test and stool antigen test to confirm active infection.
3) What treatments help heal gastric ulcers?
PPIs for acid suppression, H. pylori eradication when present, and NSAID modification; endoscopic or surgical management for complications.
4) Which lifestyle measures help prevent ulcers?
Avoid tobacco, limit alcohol, use NSAIDs judiciously (with medical advice), maintain balanced nutrition, and address stress.
5) What trends are emerging in ulcer care?
Movement toward personalized therapy, advanced endoscopic imaging, AI-assisted diagnostics, and strategies to overcome antibiotic resistance in H. pylori.
Disclaimer: This article is based on current medical evidence and reputable sources. It is intended for general informational purposes only and should not be taken as medical advice. Individuals with a history of ulcer complications or bleeding, suspected H. pylori infection, Crohn’s disease, chronic NSAID use, major health conditions (such as cardiovascular, kidney, or liver disease), pregnancy, or warning symptoms—such as gastrointestinal bleeding, weight loss, persistent vomiting, anemia, or severe pain—should seek evaluation and guidance from a qualified healthcare professional.
